Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial.

Yongchuan Chen,Heping Yang,Gensheng Lu,Xiongfei Wu,Wenxiang Huang,Yamei Wu,Xiaoju Lv,Guoming Wu,Genfu Zhang,Qiang Li,Yinghao Sun

Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial.

2012

Yongchuan Chen
Heping Yang
Gensheng Lu
Xiongfei Wu
Wenxiang Huang
Yamei Wu
Xiaoju Lv
Guoming Wu
Genfu Zhang
Qiang Li
Yinghao Sun

Background: Prulifloxacin is a promising fluoroquinolone antibiotic. A multicentre, double-blind, randomized clinical study was designed to evaluate its efficacy

Keywords:

Immunology
Clinical trial
Biology
Prulifloxacin
Levofloxacin
Respiratory system
Urinary system
Internal medicine
Fluoroquinolone Antibiotic
double blind
clinical study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations